Reversible growth factor dependency and autonomy during murine myelomonocytic leukemia induced by oncogenes

Yazar: Metcalf, Donald, Glaser, Stefan P., Xu, Zhen, Di Rago, Ladina, Mifsud, Sandra
Baskı/Yayın Bilgisi 2013

Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice

Yazar: Bilardi, Rebecca A, Anstee, Natasha S, Glaser, Stefan P, Robati, Mikara, Vandenberg, Cassandra J, Cory, Suzanne
Yayımlandı Cell Death Dis (2016)

Site-specific recombinatorics: in situ cellular barcoding with the Cre Lox system

Yazar: Weber, Tom S., Dukes, Mark, Miles, Denise C., Glaser, Stefan P., Naik, Shalin H., Duffy, Ken R.
Yayımlandı BMC Syst Biol (2016)

Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis

Yazar: Okamoto, Toru, Coultas, Leigh, Metcalf, Donald, van Delft, Mark F., Glaser, Stefan P., Takiguchi, Megumi, Strasser, Andreas, Bouillet, Philippe, Adams, Jerry M., Huang, David C. S.
Baskı/Yayın Bilgisi 2014

Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells

Yazar: Ushiki, Takashi, Huntington, Nicholas D., Glaser, Stefan P., Kiu, Hiu, Georgiou, Angela, Zhang, Jian-Guo, Metcalf, Donald, Nicola, Nicos A., Roberts, Andrew W., Alexander, Warren S.
Yayımlandı PLoS One (2016)

Mcl-1 is essential for the survival of plasma cells

Yazar: Peperzak, Victor, Vikström, Ingela, Walker, Jennifer, Glaser, Stefan P, LePage, Melanie, Coquery, Christine M, Erickson, Loren D, Fairfax, Kirsten, Mackay, Fabienne, Strasser, Andreas, Nutt, Stephen L, Tarlinton, David M
Baskı/Yayın Bilgisi 2013

Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a

Yazar: Shields, Benjamin J., Jackson, Jacob T., Metcalf, Donald, Shi, Wei, Huang, Qiutong, Garnham, Alexandra L., Glaser, Stefan P., Beck, Dominik, Pimanda, John E., Bogue, Clifford W., Smyth, Gordon K., Alexander, Warren S., McCormack, Matthew P.
Yayımlandı Genes Dev (2016)

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

Yazar: Glaser, Stefan P., Lee, Erinna F., Trounson, Evelyn, Bouillet, Philippe, Wei, Andrew, Fairlie, W. Douglas, Izon, David J., Zuber, Johannes, Rappaport, Amy R., Herold, Marco J., Alexander, Warren S., Lowe, Scott W., Robb, Lorraine, Strasser, Andreas
Baskı/Yayın Bilgisi 2012

HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia

Yazar: Brumatti, Gabriela, Salmanidis, Marika, Kok, Chung H, Bilardi, Rebecca A, Sandow, Jarrod J, Silke, Natasha, Mason, Kylie, Visser, Jolanda, Jabbour, Anissa M, Glaser, Stefan P, Okamoto, Toru, Bouillet, Philippe, D'Andrea, Richard J, Ekert, Paul G
Baskı/Yayın Bilgisi 2013

BCL‐XL exerts a protective role against anemia caused by radiation‐induced kidney damage

Yazar: Brinkmann, Kerstin, Waring, Paul, Glaser, Stefan P, Wimmer, Verena, Cottle, Denny L, Tham, Ming Shen, Nhu, Duong, Whitehead, Lachlan, Delbridge, Alex RD, Lessene, Guillaume, Smyth, Ian M, Herold, Marco J, Kelly, Gemma L, Grabow, Stephanie, Strasser, Andreas
Yayımlandı EMBO J (2020)

MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL

Yazar: Vikström, Ingela B, Slomp, Anne, Carrington, Emma M, Moesbergen, Laura M, Chang, Catherine, Kelly, Gemma L, Glaser, Stefan P, Jansen, J H Marco, Leusen, Jeanette H W, Strasser, Andreas, Huang, David C S, Lew, Andrew M, Peperzak, Victor, Tarlinton, David M
Yayımlandı Cell Death Dis (2016)

Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

Yazar: Mérino, Delphine, Khaw, Seong L., Glaser, Stefan P., Anderson, Daniel J., Belmont, Lisa D., Wong, Chihunt, Yue, Peng, Robati, Mikara, Phipson, Belinda, Fairlie, Walter D., Lee, Erinna F., Campbell, Kirsteen J., Vandenberg, Cassandra J., Cory, Suzanne, Roberts, Andrew W., Ludlam, Mary J. C., Huang, David C. S., Bouillet, Philippe
Baskı/Yayın Bilgisi 2012

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

Yazar: Kelly, Gemma L., Grabow, Stephanie, Glaser, Stefan P., Fitzsimmons, Leah, Aubrey, Brandon J., Okamoto, Toru, Valente, Liz J., Robati, Mikara, Tai, Lin, Fairlie, W. Douglas, Lee, Erinna F., Lindstrom, Mikael S., Wiman, Klas G., Huang, David C.S., Bouillet, Philippe, Rowe, Martin, Rickinson, Alan B., Herold, Marco J., Strasser, Andreas
Baskı/Yayın Bilgisi 2014